UA18249A - Спосіб одержаhhя кристалів дигідрата гідрохлориду оhдаhсетроhа змеhшеhого розміру - Google Patents

Спосіб одержаhhя кристалів дигідрата гідрохлориду оhдаhсетроhа змеhшеhого розміру

Info

Publication number
UA18249A
UA18249A UA4830462A UA4830462A UA18249A UA 18249 A UA18249 A UA 18249A UA 4830462 A UA4830462 A UA 4830462A UA 4830462 A UA4830462 A UA 4830462A UA 18249 A UA18249 A UA 18249A
Authority
UA
Ukraine
Prior art keywords
dihydrate
ondansetron hydrochloride
preparation
less
reduced size
Prior art date
Application number
UA4830462A
Other languages
English (en)
Russian (ru)
Inventor
Тревор Коллін Девід
Original Assignee
Глексо Груп Лімітед
Глексо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10659180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA18249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глексо Груп Лімітед, Глексо Груп Лимитед filed Critical Глексо Груп Лімітед
Publication of UA18249A publication Critical patent/UA18249A/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Otolaryngology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)

Abstract

Спосіб одержання кристалів дигідрату гідрохлориду ондансетрону зменшеного розміру, одержаного шляхом кристалізації з суміші водних розчинників. Дигідрат гідрохлориду ондансетрону десольвують за допомогою сушіння при температурі не нижче 40 °C і при атмосферному або зниженому тиску, рівному 200 мм рт.ст, або менше. Потім регідратують з отриманням кристалічного дигідрату гідрохлориду ондансетрону, в якому 100 мас.% кристалів мають розмір менше ніж 250 мкм і не менше 80 мас.% кристалів мають розмір менш ніж 63 мкм.
UA4830462A 1989-06-28 1990-06-27 Спосіб одержаhhя кристалів дигідрата гідрохлориду оhдаhсетроhа змеhшеhого розміру UA18249A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898914804A GB8914804D0 (en) 1989-06-28 1989-06-28 Process

Publications (1)

Publication Number Publication Date
UA18249A true UA18249A (uk) 1997-12-25

Family

ID=10659180

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4830462A UA18249A (uk) 1989-06-28 1990-06-27 Спосіб одержаhhя кристалів дигідрата гідрохлориду оhдаhсетроhа змеhшеhого розміру

Country Status (20)

Country Link
US (1) US5622720A (uk)
EP (1) EP0415522B1 (uk)
JP (1) JP3093242B2 (uk)
KR (1) KR0182789B1 (uk)
AT (1) ATE110380T1 (uk)
AU (1) AU637110B2 (uk)
CA (1) CA2019944C (uk)
DE (1) DE69011786T2 (uk)
DK (1) DK0415522T3 (uk)
ES (1) ES2060045T3 (uk)
GB (1) GB8914804D0 (uk)
HK (1) HK44495A (uk)
HU (1) HU208009B (uk)
IE (1) IE64715B1 (uk)
IL (1) IL94888A (uk)
NZ (1) NZ234267A (uk)
RU (1) RU2002745C1 (uk)
SA (1) SA90110025B1 (uk)
UA (1) UA18249A (uk)
ZA (1) ZA905002B (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
RU2162695C1 (ru) * 2000-07-14 2001-02-10 ООО с иностранными инвестициями "Редди-Биомед лимитед" Способ получения ондансетрона гидрохлорида дигидрата, субстанция и фармацевтический препарат
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
RU2185825C1 (ru) * 2001-03-12 2002-07-27 Государственный научный центр - Институт биофизики Фармацевтическая композиция, содержащая ондансетрон и метацин
CN100379723C (zh) * 2002-02-19 2008-04-09 特瓦制药工业有限公司 阿托伐他汀半钙脱溶剂的方法和基本上不含有机溶剂的阿托伐他汀半钙
EP1485344A1 (en) 2002-03-28 2004-12-15 Synthon B.V. Venlafaxine besylate
PT1499623E (pt) * 2002-04-29 2007-08-10 Teva Gyogyszergyar Zartkoeruee ''processo papa a preparação de 1, 2, 3, 9-tetra-hidro-9-metil-3- [(2-metil-1h-imidazol-1-il) metil] -4h-carbazol-4-ona''
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
DE10393729T5 (de) * 2002-11-15 2005-10-13 Helsinn Healthcare S.A. Verfahren zur Behandlung von Emesis
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
WO2005108392A2 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
WO2006091657A1 (en) * 2005-02-23 2006-08-31 Teva Pharmaceutical Industries, Ltd. Rasagiline formulations of improved content uniformity
ZA200707469B (en) * 2005-02-23 2008-11-26 Teva Pharma Rasagiline formulations of improved content uniformity
JP5769923B2 (ja) 2006-04-03 2015-08-26 テバ ファーマシューティカル インダストリーズ リミティド レストレスレッグス症候群の治療のためのラサギリンの使用
CN101573106B (zh) * 2006-10-24 2013-07-24 赫尔辛医疗股份公司 具有改进的稳定性和生物利用度的含帕洛司琼盐酸盐的软胶囊剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88268I2 (uk) * 1984-01-25 1994-02-03
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0275668B1 (en) * 1986-12-17 1992-09-30 Glaxo Group Limited Use of ketone derivatives in the treatment of cognitive disorders
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron

Also Published As

Publication number Publication date
JP3093242B2 (ja) 2000-10-03
SA90110025B1 (ar) 2001-03-24
HK44495A (en) 1995-03-31
AU5787490A (en) 1991-01-03
IL94888A0 (en) 1991-04-15
ES2060045T3 (es) 1994-11-16
EP0415522A1 (en) 1991-03-06
IL94888A (en) 1995-03-15
JPH0395178A (ja) 1991-04-19
HU904015D0 (en) 1990-12-28
CA2019944A1 (en) 1990-12-28
ATE110380T1 (de) 1994-09-15
NZ234267A (en) 1992-11-25
IE64715B1 (en) 1995-08-23
AU637110B2 (en) 1993-05-20
KR0182789B1 (ko) 1999-10-15
DE69011786T2 (de) 1994-12-15
KR910000709A (ko) 1991-01-30
RU2002745C1 (ru) 1993-11-15
DK0415522T3 (da) 1994-09-19
IE902333L (en) 1990-12-28
HUT54140A (en) 1991-01-28
CA2019944C (en) 2000-05-09
DE69011786D1 (de) 1994-09-29
US5622720A (en) 1997-04-22
GB8914804D0 (en) 1989-08-16
IE902333A1 (en) 1991-01-16
HU208009B (en) 1993-07-28
EP0415522B1 (en) 1994-08-24
ZA905002B (en) 1991-12-24

Similar Documents

Publication Publication Date Title
UA18249A (uk) Спосіб одержаhhя кристалів дигідрата гідрохлориду оhдаhсетроhа змеhшеhого розміру
JPS5232899A (en) Process for production of cubic boron nitride
JPS5239653A (en) Process for preparing antibiotics of 3',4'-dideoxykanamycin b derivati ves
ES439261A1 (es) Procedimiento para preparar acido 5-(2-hidroxi-n-propoxi)-4-oxo-8-n-propil-4h-1-benzopiran-2-carboxilico.
JPS5422323A (en) Preparation of urea for industrial uses
JPS51146482A (en) Process for preparing n1-(2- tetrahydrofuryl)-5-fluorouracil
JPS52131510A (en) Preparation of 6-methyl-5-heptene-2-one
JPS5232900A (en) Process for production of cubic boron nitride
JPS525700A (en) The process for production of silicon nitride
JPS51143633A (en) Process for preparation of novel epoxy compounds
JPS51113882A (en) Method for preparing 1-(alpha -alkoxyalkyl)-uracil derivatives
JPS5283421A (en) Preparation of phenoxypropylamine derivatives
JPS5337626A (en) Preparation of n-substituted aniline derivatives
JPS51133251A (en) Process for preparing aminocyclitol derivatives
JPS53144562A (en) Preparation of steroid derivatives
JPS56128770A (en) N-amino-5-fluorouracil and its preparation
JPS51123064A (en) Forming process of bonding-pad area
JPS5229496A (en) Process for continuous production of anhydrous sodium dithionite
Suda Studies on the Drawing of Cellulose Acetate Films
JPS5251346A (en) Preparation of cyclopentenone derivatives
JPS5232897A (en) Process for production of cubnic boron nitride
Ikoma Studies on the Higher Treatment of Silk
AU215103B2 (en) Mercury derivatives of 1, 6, 8-triazabicyclo (4, 3, 0 nonane-7, 9-dione andn-substituted derivatives thereof and processes for preparing them
JPS53144563A (en) Preparation of steroid derivatives
JPS5251347A (en) Preparation of cyclopentenone derivatives